529 related articles for article (PubMed ID: 18176998)
1. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
[TBL] [Abstract][Full Text] [Related]
2. Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain.
Scanio MJ; Shi L; Drizin I; Gregg RJ; Atkinson RN; Thomas JB; Johnson MS; Chapman ML; Liu D; Krambis MJ; Liu Y; Shieh CC; Zhang X; Simler GH; Joshi S; Honore P; Marsh KC; Knox A; Werness S; Antonio B; Krafte DS; Jarvis MF; Faltynek CR; Marron BE; Kort ME
Bioorg Med Chem; 2010 Nov; 18(22):7816-25. PubMed ID: 20965738
[TBL] [Abstract][Full Text] [Related]
3. A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.
Jarvis MF; Honore P; Shieh CC; Chapman M; Joshi S; Zhang XF; Kort M; Carroll W; Marron B; Atkinson R; Thomas J; Liu D; Krambis M; Liu Y; McGaraughty S; Chu K; Roeloffs R; Zhong C; Mikusa JP; Hernandez G; Gauvin D; Wade C; Zhu C; Pai M; Scanio M; Shi L; Drizin I; Gregg R; Matulenko M; Hakeem A; Gross M; Johnson M; Marsh K; Wagoner PK; Sullivan JP; Faltynek CR; Krafte DS
Proc Natl Acad Sci U S A; 2007 May; 104(20):8520-5. PubMed ID: 17483457
[TBL] [Abstract][Full Text] [Related]
4. Heterologous expression and functional analysis of rat Nav1.8 (SNS) voltage-gated sodium channels in the dorsal root ganglion neuroblastoma cell line ND7-23.
John VH; Main MJ; Powell AJ; Gladwell ZM; Hick C; Sidhu HS; Clare JJ; Tate S; Trezise DJ
Neuropharmacology; 2004 Mar; 46(3):425-38. PubMed ID: 14975698
[TBL] [Abstract][Full Text] [Related]
5. 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.
Macsari I; Besidski Y; Csjernyik G; Nilsson LI; Sandberg L; Yngve U; Ahlin K; Bueters T; Eriksson AB; Lund PE; Venyike E; Oerther S; Hygge Blakeman K; Luo L; Arvidsson PI
J Med Chem; 2012 Aug; 55(15):6866-80. PubMed ID: 22770500
[TBL] [Abstract][Full Text] [Related]
6. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.
Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME
Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613
[TBL] [Abstract][Full Text] [Related]
8. Relationship between sodium channel NaV1.3 expression and neuropathic pain behavior in rats.
Lindia JA; Köhler MG; Martin WJ; Abbadie C
Pain; 2005 Sep; 117(1-2):145-53. PubMed ID: 16061326
[TBL] [Abstract][Full Text] [Related]
9. Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.
Bregman H; Berry L; Buchanan JL; Chen A; Du B; Feric E; Hierl M; Huang L; Immke D; Janosky B; Johnson D; Li X; Ligutti J; Liu D; Malmberg A; Matson D; McDermott J; Miu P; Nguyen HN; Patel VF; Waldon D; Wilenkin B; Zheng XM; Zou A; McDonough SI; DiMauro EF
J Med Chem; 2011 Jul; 54(13):4427-45. PubMed ID: 21634377
[TBL] [Abstract][Full Text] [Related]
10. Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons.
Rush AM; Craner MJ; Kageyama T; Dib-Hajj SD; Waxman SG; Ranscht B
Eur J Neurosci; 2005 Jul; 22(1):39-49. PubMed ID: 16029194
[TBL] [Abstract][Full Text] [Related]
11. Future potential and status of selective sodium channel blockers for the treatment of pain.
Priest BT
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a new class of potent inhibitors of the voltage-gated sodium channel Nav1.7.
Williams BS; Felix JP; Priest BT; Brochu RM; Dai K; Hoyt SB; London C; Tang YS; Duffy JL; Parsons WH; Kaczorowski GJ; Garcia ML
Biochemistry; 2007 Dec; 46(50):14693-703. PubMed ID: 18027973
[TBL] [Abstract][Full Text] [Related]
13. Thiamine suppresses thermal hyperalgesia, inhibits hyperexcitability, and lessens alterations of sodium currents in injured, dorsal root ganglion neurons in rats.
Song XS; Huang ZJ; Song XJ
Anesthesiology; 2009 Feb; 110(2):387-400. PubMed ID: 19194165
[TBL] [Abstract][Full Text] [Related]
14. Functional tetrodotoxin-resistant Na(+) channels are expressed presynaptically in rat dorsal root ganglia neurons.
Medvedeva YV; Kim MS; Schnizler K; Usachev YM
Neuroscience; 2009 Mar; 159(2):559-69. PubMed ID: 19162133
[TBL] [Abstract][Full Text] [Related]
15. Reversal of neuropathic pain by alpha-hydroxyphenylamide: a novel sodium channel antagonist.
Ko SH; Jochnowitz N; Lenkowski PW; Batts TW; Davis GC; Martin WJ; Brown ML; Patel MK
Neuropharmacology; 2006 Jun; 50(7):865-73. PubMed ID: 16464480
[TBL] [Abstract][Full Text] [Related]
16. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models.
Joshi SK; Honore P; Hernandez G; Schmidt R; Gomtsyan A; Scanio M; Kort M; Jarvis MF
J Pain; 2009 Mar; 10(3):306-15. PubMed ID: 19070548
[TBL] [Abstract][Full Text] [Related]
17. Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels.
Zhou X; Dong XW; Crona J; Maguire M; Priestley T
J Pharmacol Exp Ther; 2003 Aug; 306(2):498-504. PubMed ID: 12730276
[TBL] [Abstract][Full Text] [Related]
18. Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons.
Herzog RI; Cummins TR; Ghassemi F; Dib-Hajj SD; Waxman SG
J Physiol; 2003 Sep; 551(Pt 3):741-50. PubMed ID: 12843211
[TBL] [Abstract][Full Text] [Related]
19. A selective Nav1.8 sodium channel blocker, A-803467 [5-(4-chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], attenuates spinal neuronal activity in neuropathic rats.
McGaraughty S; Chu KL; Scanio MJ; Kort ME; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2008 Mar; 324(3):1204-11. PubMed ID: 18089840
[TBL] [Abstract][Full Text] [Related]
20. Analysis of human Nav1.8 expressed in SH-SY5Y neuroblastoma cells.
Dekker LV; Daniels Z; Hick C; Elsegood K; Bowden S; Szestak T; Burley JR; Southan A; Cronk D; James IF
Eur J Pharmacol; 2005 Dec; 528(1-3):52-8. PubMed ID: 16325806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
